top of page
Recobia Therapeutics

Supported projects

Recobia Therapeutics

Is developing an innovative platform of biocompatible, biodegradable polysaccharide-based hydrocolloid gels for the controlled subcutaneous release of therapeutic antibodies and ADCs. This approach aims to make biological cancer treatments more accessible by facilitating rapid, convenient subcutaneous administration for patients and hospitals.

Recobia Therapeutics
linkedin

PSCC's entrance

December 2024

Localization

FR - Grand Est

Modality

Targeted therapy

Development status

Biotech - Lead optimization

Award(s)

bottom of page